|
Advisory Committees
Nature and Basis Statements of Conflict(s) of Interest for Voting Members of FDA Advisory Committee Members
The Agency is revising its procedures regarding the disclosure of conflicts of interest and waivers for voting advisory committee members in order to implement the requirements of section 795 of Pub. L. No. 109-97 (Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2006) (Nov. 10, 2005). This information is being provided as an interim measure to comply with the requirements of this law.
Science Board for the Food and Drug Administration
March 31, 2006 Meeting
Gail H. Cassell Ph.D.
- 18 U.S.C. 208 waiver - General Matters (pdf)
Susan Kay Harlander, Ph.D.
- 18 U.S.C. 208 waiver - General Matters (pdf)
Cato T. Laurencin M.D., Ph.D.
- 18 U.S.C. 208 waiver - General Matters (pdf)
Barbara McNeil M.D., Ph.D.
- 18 U.S.C. 208 waiver - General Matters (pdf)
F. Xavier Pi-Sunyer M.D., M.P.H.
- 18 U.S.C. 208 waiver - General Matters (pdf)
Allen D. Roses., M.D.
- 18 U.S.C. 208 waiver - General Matters (pdf)
Kenneth I. Shine M.D.
- 18 U.S.C. 208 waiver - General Matters (pdf)
Katherine M.J. Swanson, Ph.D.
- 18 U.S.C. 208 waiver - General Matters (pdf)
Lonnie J. King, Ph.D.
- 18 U.S.C. 208 waiver - General Matters (pdf)
David R. Parkinson, M.D.
- 18 U.S.C. 208 waiver - General Matters (pdf)
Page updated:
June 6, 2006
|
|